AN2 Therapeutics
ANTX
#8920
Rank
C$0.27 B
Marketcap
C$7.29
Share price
-2.68%
Change (1 day)
373.99%
Change (1 year)

EPS for AN2 Therapeutics (ANTX)

EPS in 2026 (TTM): C-$1.49

According to AN2 Therapeutics's latest financial reports the company's current EPS (TTM) is C-$1.53. In 2025 the company made an earnings per share (EPS) of C-$1.66 an increase over its 2024 EPS that were of C-$2.47.

EPS history for AN2 Therapeutics from 2022 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$1.49-10.57%
2025C-$1.66-32.56%
2024C-$2.47-39.01%
2023C-$4.04-40.02%
2022C-$6.74